NCT07454226 2026-04-16
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Not yet recruiting
Clinical Trials
57 trialsNCT06681363 2026-04-15
LANA
Nantes University Hospital
Not yet recruiting
NCT07008027 2026-04-15
Real World Asparaginase Therapy Toxicity
St. Jude Children's Research Hospital
Not yet recruiting
NCT07192237 2026-04-15
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT07522905 2026-04-15
Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission
Comenius University
Phase NA Not yet recruiting
NCT07529223 2026-04-14
ASTRA
Centre Hospitalier Universitaire de Nice
Phase NA Not yet recruiting
NCT07313592 2026-04-13
Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients
Washington University School of Medicine
Not yet recruiting
NCT07469592 2026-04-13
eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation
University of Miami
Phase NA Not yet recruiting
NCT07516353 2026-04-08
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
Dana-Farber Cancer Institute
Phase NA Not yet recruiting
NCT07518654 2026-04-08
ThINKK-01
St. Justine's Hospital
Phase 1 Not yet recruiting
NCT07254793 2026-04-07
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
University of Arizona
Phase 1 Not yet recruiting
NCT07509385 2026-04-03
The Role of Serum Cytokines IL_17 A and IL_10 in Disease Activity of Acute B Lymphoblastic Leukemia in South Egypt
Assiut University
Not yet recruiting
NCT07221656 2026-04-02
Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
Mayo Clinic
Not yet recruiting
NCT07495631 2026-03-27
Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Not yet recruiting
NCT06739447 2026-03-23
Hospital Based Continuous Patient Monitoring System
University of Alabama at Birmingham
Phase NA Not yet recruiting
NCT07483476 2026-03-19
CIRCALL
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
NCT07483749 2026-03-19
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
The Children's Hospital of Zhejiang University School of Medicine
Not yet recruiting
NCT07462299 2026-03-10
NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy
The Children's Hospital of Zhejiang University School of Medicine
Phase NA Not yet recruiting
NCT07178912 2026-03-09
Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT06446661 2026-03-04
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
University of Chicago
Phase NA Not yet recruiting
NCT05565105 2026-03-03
CD34+ Transplants for Leukemia and Lymphoma
Baptist Health South Florida
Phase 2 Not yet recruiting
NCT07443592 2026-03-02
LAL-2025
PETHEMA Foundation
Phase NA Not yet recruiting
NCT07428486 2026-02-23
A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
Phase 1 Not yet recruiting
NCT07374315 2026-02-12
Weight Gain in Pediatric Leukemia Survivors
Washington University School of Medicine
Phase NA Not yet recruiting
NCT06991920 2026-02-11
Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Not yet recruiting
NCT07371533 2026-01-28
A-319
Shanxi Bethune Hospital
Phase NA Not yet recruiting
NCT07356960 2026-01-21
PONA4ALL Ph+
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not yet recruiting
NCT07320534 2026-01-08
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Gadjah Mada University
Phase 4 Not yet recruiting
NCT07319481 2026-01-06
Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia
The Hong Kong Polytechnic University
Phase NA Not yet recruiting
NCT07166549 2025-12-24
BaseCAR-01
University Hospital, Basel, Switzerland
Phase 1 Not yet recruiting
NCT07301138 2025-12-24
BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients
Ruijin Hospital
Phase 2 Not yet recruiting
NCT07301424 2025-12-24
Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
University of Alberta
Phase 2 Not yet recruiting
NCT07283640 2025-12-22
A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
Phase 1 Not yet recruiting
NCT07297914 2025-12-22
FORUM2
Bambino Gesù Hospital and Research Institute
Phase 2/3 Not yet recruiting
NCT06303687 2025-11-24
VR-PAT and fNIRS to Identify CNS Biomarkers of Pain
Nationwide Children's Hospital
Phase NA Not yet recruiting
NCT07227584 2025-11-12
ALL Backbone in AYAs
Dana-Farber Cancer Institute
Phase 2 Not yet recruiting
NCT06570915 2025-10-01
T-ALL-2024
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Not yet recruiting
NCT07175415 2025-09-16
HEM-iSMART E
Princess Maxima Center for Pediatric Oncology
Phase 1/2 Not yet recruiting
NCT04464603 2025-08-19
InterFACE
Pediatric Clinical Research Platform
Phase NA Not yet recruiting
NCT05779930 2025-08-15
Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
Nationwide Children's Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07113132 2025-08-08
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia
Assiut University
Not yet recruiting
NCT06930105 2025-08-06
Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALL
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Not yet recruiting
NCT07108010 2025-08-06
ABO and Rh Blood Group Frequencies in Acute Leukemia Patients
Assiut University
Not yet recruiting
NCT07042932 2025-06-29
OPAC-ALL
Rigshospitalet, Denmark
Phase NA Not yet recruiting
NCT07032181 2025-06-22
The Effect of Non-pharmacological Methods on Pain, Fear
Fenerbahce University
Phase NA Not yet recruiting
NCT06861348 2025-03-06
ZJU-HSCT-INO
First Affiliated Hospital of Zhejiang University
Phase 2 Not yet recruiting
NCT06846294 2025-02-26
BREVARY
University of Exeter
Phase NA Not yet recruiting
NCT06790719 2025-01-24
BEACON
University of Southampton
Not yet recruiting
NCT06777264 2025-01-15
JUVENTAS-ALL05
First Affiliated Hospital of Zhejiang University
Phase 2 Not yet recruiting
NCT06746571 2024-12-24
Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients
Sohag University
Phase NA Not yet recruiting